Default: Current Medical Research and Opinion

ISSN: 0300-7995

Journal Home

Journal Guideline

Current Medical Research and Opinion Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Medical Research and Opinion is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 107. It has a price of 4000 €. It has an SJR impact factor of 0,708 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,708.

Current Medical Research and Opinion focuses its scope in these topics and keywords: treatment, patients, observational, safety, randomized, delivery, efficacy, clinical, study, results, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Current Medical Research and Opinion

0,708

SJR Impact factor

107

H Index

239

Total Docs (Last Year)

824

Total Docs (3 years)

9318

Total Refs

1687

Total Cites (3 years)

740

Citable Docs (3 years)

2,08

Cites/Doc (2 years)

38,99

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


treatment, patients, observational, safety, randomized, delivery, efficacy, clinical, study, results, review, pain, quality, type, buprenorphine, diabetes, combination, oral, practice, doubleblind, release, systematic, weight, controlled, infection,



Best articles by citations

Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension

View more

Functional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease

View more

The impact of migraine on work, family, and leisure among young women -a multinational study

View more

Clinical Implications of Dopamine Research in Schizophrenia

View more

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

View more

Focus on Amisulpride

View more

Focus on anastrozole and breast cancer

View more

Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome

View more

The value of post-marketing medication surveys in Parkinson's disease

View more

The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol

View more

Low-density lipoprotein 4: a novel predictor of coronary artery disease severity

View more

The Choice of Antihypertensive Drugs in Patients with Erectile Dysfunction

View more
SHOW MORE ARTICLES

Deleterious Effects of Increased Body Weight Associated with Intensive Insulin Therapy for Type 1 Diabetes: Increased Blood Pressure and Worsened Lipid Profile Partially Negate Improvements in Life Expectancy

View more

Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort

View more

Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study

View more

Differences in Lipid Profiles of Patients Given Rosiglitazone Followed by Pioglitazone

View more

Low Serum Levels of High-density Lipoprotein Cholesterol and Hypolipidaemic Treatment

View more

Treatment of Overactive Bladder with Once-daily Extended-release Tolterodine or Oxybutynin: The Antimuscarinic Clinical Effectiveness Trial (ACET)

View more

Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis

View more

What Impact Would Pancreatic Beta-cell Preservation Have on Life Expectancy, Quality-adjusted Life Expectancy and Costs of Complications in Patients with Type 2 Diabetes? A Projection Using the CORE Diabetes Model

View more

No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment

View more

Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis

View more

A Comparison of Adverse Renovascular Experiences Among Osteoarthritis Patients Treated with Rofecoxib and Comparator Non-selective Non-steroidal Anti-inflammatory Agents

View more

Patient and Physician Satisfaction with Aceclofenac: Results of the European Observational Cohort Study (Experience with Aceclofenac for Inflammatory Pain in Daily Practice)

View more

FAQS